SCHEMBL7380718

SCHEMBL7380718

O=C(OCc1ccco1)N(S)S

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
MAPK1 P28482 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
POLB P06746 2/20 0.47
TSHR P16473 2/20 0.47
MAPT P10636 2/20 0.45
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
LMNA P02545 1/20 0.45
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44
SLC1A1 P43005 1/20 0.44
ALOX5 P09917 1/20 0.44
GAA P10253 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11002356 0.80 ALDH1A1 (0.68) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL14991432 0.80 ALDH1A1 (0.72) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL6443452 0.78 ALDH1A1 (0.70) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL6443447 0.78 ALDH1A1 (0.70) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL22982168 0.78 ALDH1A1 (0.60) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL8965092 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL4624403 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL10998807 0.77 ALDH1A1 (0.64) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL11002726 0.77 ALDH1A1 (0.68) ALDH1A1MAPK1TDP1POLBTSHR
SCHEMBL3785783 0.77 ALDH1A1 (0.68) ALDH1A1MAPK1TDP1POLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019034-A2 ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS Atherogenics, Inc. (US) 2000-07-19 EP disclosed
WO-1999001118-A9 ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS ATHEROGENICS INC (US) 1999-05-20 WO disclosed
WO-1999001118-A2 ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS ATHEROGENICS, INC. (US) 1999-01-14 WO disclosed